These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18945771)

  • 1. Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors.
    Bailey JR; Brennan TP; O'Connell KA; Siliciano RF; Blankson JN
    J Virol; 2009 Jan; 83(1):88-97. PubMed ID: 18945771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors.
    Salgado M; Brennan TP; O'Connell KA; Bailey JR; Ray SC; Siliciano RF; Blankson JN
    Retrovirology; 2010 Nov; 7():94. PubMed ID: 21059238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape.
    Bailey JR; Zhang H; Wegweiser BW; Yang HC; Herrera L; Ahonkhai A; Williams TM; Siliciano RF; Blankson JN
    J Infect Dis; 2007 Jul; 196(1):50-5. PubMed ID: 17538883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.
    Bailey JR; O'Connell K; Yang HC; Han Y; Xu J; Jilek B; Williams TM; Ray SC; Siliciano RF; Blankson JN
    J Virol; 2008 Aug; 82(15):7395-410. PubMed ID: 18495769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
    Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
    J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllers.
    Miura T; Brumme CJ; Brockman MA; Brumme ZL; Pereyra F; Block BL; Trocha A; John M; Mallal S; Harrigan PR; Walker BD
    J Virol; 2009 Apr; 83(7):3407-12. PubMed ID: 19153230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.
    Navis M; Schellens IM; van Swieten P; Borghans JA; Miedema F; Kootstra NA; van Baarle D; Schuitemaker H
    J Infect Dis; 2008 Mar; 197(6):871-9. PubMed ID: 18279072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-specific CD8+ T cell responses and viral evolution in women and infants.
    Sanchez-Merino V; Nie S; Luzuriaga K
    J Immunol; 2005 Nov; 175(10):6976-86. PubMed ID: 16272358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.
    Salgado M; Swanson MD; Pohlmeyer CW; Buckheit RW; Wu J; Archin NM; Williams TM; Margolis DM; Siliciano RF; Garcia JV; Blankson JN
    J Virol; 2014 Mar; 88(6):3340-52. PubMed ID: 24390323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control.
    Xie J; Lu W; Samri A; Costagliola D; Schnuriger A; da Silva BC; Blanc C; Larsen M; Theodorou I; Rouzioux C; Autran B;
    AIDS; 2010 Sep; 24(15):2323-9. PubMed ID: 20802296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
    Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
    PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.
    Bailey JR; Williams TM; Siliciano RF; Blankson JN
    J Exp Med; 2006 May; 203(5):1357-69. PubMed ID: 16682496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
    Bansal A; Yue L; Conway J; Yusim K; Tang J; Kappes J; Kaslow RA; Wilson CM; Goepfert PA
    AIDS; 2007 Nov; 21(18):2387-97. PubMed ID: 18025875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strain.
    Braibant M; Xie J; Samri A; Agut H; Autran B; Barin F
    Virology; 2010 Sep; 405(1):81-92. PubMed ID: 20561662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss.
    Watkins RL; Foster JL; Garcia JV
    Retrovirology; 2015 Jul; 12():61. PubMed ID: 26169178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
    Kiepiela P; Leslie AJ; Honeyborne I; Ramduth D; Thobakgale C; Chetty S; Rathnavalu P; Moore C; Pfafferott KJ; Hilton L; Zimbwa P; Moore S; Allen T; Brander C; Addo MM; Altfeld M; James I; Mallal S; Bunce M; Barber LD; Szinger J; Day C; Klenerman P; Mullins J; Korber B; Coovadia HM; Walker BD; Goulder PJ
    Nature; 2004 Dec; 432(7018):769-75. PubMed ID: 15592417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.
    O'Connell KA; Brennan TP; Bailey JR; Ray SC; Siliciano RF; Blankson JN
    J Virol; 2010 Jul; 84(14):7018-28. PubMed ID: 20444904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of CD8 T cell responses to changing HIV-1 sequences in a cohort of HIV-1 infected individuals not selected for a certain HLA allele.
    Roider J; Kalteis AL; Vollbrecht T; Gloning L; Stirner R; Henrich N; Bogner JR; Draenert R
    PLoS One; 2013; 8(12):e80045. PubMed ID: 24312453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Immunodominance Hierarchy of CD8
    Adland E; Hill M; Lavandier N; Csala A; Edwards A; Chen F; Radkowski M; Kowalska JD; Paraskevis D; Hatzakis A; Valenzuela-Ponce H; Pfafferott K; Williams I; Pellegrino P; Borrow P; Mori M; Rockstroh J; Prado JG; Mothe B; Dalmau J; Martinez-Picado J; Tudor-Williams G; Frater J; Stryhn A; Buus S; Teran GR; Mallal S; John M; Buchbinder S; Kirk G; Martin J; Michael N; Fellay J; Deeks S; Walker B; Avila-Rios S; Cole D; Brander C; Carrington M; Goulder P
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
    López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
    Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.